Biotech Boom-Bust and SPACs

Jim cautions about biotech valuations, takeover-driven pops, and SPAC-related speculative risks.

Play episode from 25:50

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!